Value of Cardiac Output Monitoring by Supra-sternal Doppler/Echocardiography in Intensive Care Unit

NCT03952871 | Completed

• 1 other identifier: PO18127
• Study Type: observational
• Target: 62
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to evaluate the concordance between the measurement of cardiac blood flow by non-invasive supra sternal ultrasound and the measurements performed by invasive monitoring in intensive care patients already equipped with an invasive monitoring. This invasive monitoring consists of catheters used to measure the cardiac output allowing the supply of organs and is installed when there is need to monitor the blood flow in different hemodynamic reasons. The patient's care will not be modified, the study just requires a supplementary measure in an exam already perform in the standard care. The principal hypothesis is that we can show a concordance between this non-invasive measure and the standard invasive monitoring.

Conditions

Shock

Keywords

Shock; Hemodynamic

Outcome Measures

Primary Outcomes (1)

• Concordance between the measurement of cardiac blood flow by non-invasive supra sternal ultrasound and the measurements performed by invasive monitoring

  Value of cardiac blood flow measured by supra sternal ultrasound and invasive monitoring

  Day 0

Secondary Outcomes (1)

• Concordance between the measurement of cardiac blood flow by non-invasive supra sternal ultrasound and the measurements performed by transthoracic echography

  Day 0

Study Arms (1)

Intensive care patient with hemodynamic instability

The study group is composed of intensive care patients which already need an invasive monitoring of the cardiac output because of a shock state.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients who will be included in this study are patients who already have an invasive cardiac output monitoring such as trans pulmonary thermodilution or right heart catheterization for many reason as septic shock, cardiogenic shock or any shock state.

You may qualify if:

• \- patient admitted in intensive care unit at the Reims University Hospital and in whom invasive monitoring of cardiac output is already placed.

You may not qualify if:

• \- Age under 18 yo

Sponsors & Collaborators

• CHU de Reims: lead

Study Sites (1)

Damien JOLLY

Reims, France

Location

MeSH Terms

Conditions

Shock

Condition Hierarchy (Ancestors)

Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 13, 2019
• First Posted: May 16, 2019
• Study Start: October 18, 2018
• Primary Completion: April 24, 2019
• Study Completion: April 24, 2019
• Last Updated: June 12, 2020

Record last verified: 2020-06

Locations

FR (1)